Who Supplies Heparin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Heparin exports, with 391+ registered manufacturers shipping to buyers across 137+ countries — yet a handful of companies dominate the shipments. GLAND PHARMA LTD holds the largest share at 21.0% (export value: $74.0M). Close behind, GLAND PHARMA LIMITED (11.4%, $40.1M). CAPLIN POINT LABORATORIES LIMITED (8.5%, $30.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Heparin? Top Manufacturers & Their Buyers
Flow of Heparin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Heparin Supplier Network — Key Market Intelligence
The Heparin export market from India is led by GLAND PHARMA LTD, which alone commands a 21.0% share, shipping $74.0M worth of product across 906 shipments. The second-largest exporter, GLAND PHARMA LIMITED, contributes $40.1M (11.4%) to the overall market. Combined, the top two suppliers alone account for 32.3% of all Heparin exports, indicating a relatively concentrated supply base.
Across all 391 tracked manufacturers, the total Heparin export value stands at $352.8M from 4.6K shipments. The market average shipment value is $76.9K. The single largest buyer relationship in terms of trade value is FRESENIUS KABI USA LLC,, receiving $36.4M worth of product.
The combined buyer network spans 14 named purchasing companies, including FRESENIUS KABI USA LLC,, EVERSANA, BOSTON ONCOLOGY ARABIA, EVERSANA LIFE SCIENCE SERVICES LLC, NEXT PHARMA SOURCING S.A.S and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GLAND PHARMA LTD
GLAND PHARMA LTD is the first-largest Heparin exporter from India, with a market share of 21.0% and a total export value of $74.0M across 906 shipments. Their average shipment value of $81.6K is above the market average of $76.9K, suggesting premium or bulk contract pricing.
GLAND PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FRESENIUS KABI USA LLC, — $36.4M across 445 shipments (49.2% of this supplier's total exports)
• EVERSANA — $18.1M across 221 shipments (24.4% of this supplier's total exports)
• BOSTON ONCOLOGY ARABIA — $9.3M across 114 shipments (12.5% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $7.1M across 87 shipments (9.6% of this supplier's total exports)
• NEXT PHARMA SOURCING S.A.S — $3.2M across 39 shipments (4.3% of this supplier's total exports)
Key Insight: GLAND PHARMA LTD's per-shipment value of $81.6K is 6% above the market average of $76.9K, consistent with large-order contracts or value-added formulations.
2GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the second-largest Heparin exporter from India, with a market share of 11.4% and a total export value of $40.1M across 763 shipments. Their average shipment value of $52.6K is below the market average of $76.9K, reflecting a high-volume, competitive pricing strategy.
GLAND PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FRESENIUS KABI USA LLC, — $11.6M across 220 shipments (28.9% of this supplier's total exports)
• EVERSANA — $8.9M across 168 shipments (22.1% of this supplier's total exports)
• BOSTON ONCOLOGY ARABIA — $7.5M across 143 shipments (18.8% of this supplier's total exports)
• EVERSANA EVERSANA — $7.4M across 140 shipments (18.4% of this supplier's total exports)
• ASCEND LABORATORIES SPA — $4.8M across 91 shipments (11.9% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED operates with high shipment frequency (763 shipments) at a per-shipment value of $52.6K, indicating a broad distribution network with many smaller, regular orders.
3CAPLIN POINT LABORATORIES LIMITED
CAPLIN POINT LABORATORIES LIMITED is the third-largest Heparin exporter from India, with a market share of 8.5% and a total export value of $30.1M across 74 shipments. Their average shipment value of $406.2K is above the market average of $76.9K, suggesting premium or bulk contract pricing.
CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. NUEVOS ETICOS NEOETHICALS, S.A. is the dominant customer, accounting for 94.5% of this supplier's tracked business. Top customers include:
• NUEVOS ETICOS NEOETHICALS, S.A. — $28.4M across 70 shipments (94.5% of this supplier's total exports)
• DROGUERIA SAIMED S.A — $514.3K across 1 shipments (1.7% of this supplier's total exports)
• DROGUERIA SAIMED S.A — $423.7K across 1 shipments (1.4% of this supplier's total exports)
• NUEVOS ETICOS NEOETHICALS, S.A. — $401.0K across 1 shipments (1.3% of this supplier's total exports)
• NEOETHICALS CIA LTDA — $316.4K across 1 shipments (1.1% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $406.2K is 428% above the market average of $76.9K, consistent with large-order contracts or value-added formulations.
4PFIZER HEALTHCARE INDIA PRIVATE LIMITED
PFIZER HEALTHCARE INDIA PRIVATE LIMITED is the fourth-largest Heparin exporter from India, with a market share of 7.3% and a total export value of $25.6M across 31 shipments. Their average shipment value of $826.2K is above the market average of $76.9K, suggesting premium or bulk contract pricing.
PFIZER HEALTHCARE INDIA PRIVATE LIMITED serves 2 named buyers in our database. HOSPIRA INC is the dominant customer, accounting for 63.8% of this supplier's tracked business. Top customers include:
• HOSPIRA INC — $16.3M across 20 shipments (63.8% of this supplier's total exports)
• XXSPIXX INX — $9.3M across 11 shipments (36.2% of this supplier's total exports)
Key Insight: PFIZER HEALTHCARE INDIA PRIVATE LIMITED's per-shipment value of $826.2K is 974% above the market average of $76.9K, consistent with large-order contracts or value-added formulations.
5MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Heparin exporter from India, with a market share of 2.6% and a total export value of $9.1M across 66 shipments. Their average shipment value of $138.3K is above the market average of $76.9K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 2 named buyers in our database. MYLAN INSTITUTIONAL INC 2898 is the dominant customer, accounting for 88.0% of this supplier's tracked business. Top customers include:
• MYLAN INSTITUTIONAL INC 2898 — $8.0M across 58 shipments (88.0% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC 2898 — $1.1M across 8 shipments (12.0% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $138.3K is 80% above the market average of $76.9K, consistent with large-order contracts or value-added formulations.
6SAKAR HEALTHCARE LIMITED
SAKAR HEALTHCARE LIMITED is the fifth-largest Heparin exporter from India, with a market share of 1.9% and a total export value of $6.5M across 79 shipments. Their average shipment value of $82.8K is above the market average of $76.9K, suggesting premium or bulk contract pricing.
SAKAR HEALTHCARE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NA — $2.6M across 31 shipments (39.2% of this supplier's total exports)
• TO THE ORDER OF SECU — $2.4M across 29 shipments (37.3% of this supplier's total exports)
• TO THE ORDER OF METR — $642.3K across 8 shipments (9.8% of this supplier's total exports)
• TO THE ORDER OF ASIA — $474.7K across 6 shipments (7.3% of this supplier's total exports)
• ASIA UNITED BANK — $415.6K across 5 shipments (6.4% of this supplier's total exports)
Key Insight: SAKAR HEALTHCARE LIMITED's per-shipment value of $82.8K is 8% above the market average of $76.9K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Heparin Flows
Once Heparin leaves the manufacturing plants of companies like GLAND PHARMA LTD and GLAND PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $352.8M. United States absorbs the largest share at 42.1% ($148.5M), followed by Saudi Arabia (12.3%) and Guatemala (8.7%).
In United States — the top destination — named importers include FRESENIUS KABI USA, LLC, EVERSANA, HOSPIRA INC. In Saudi Arabia, key buyers are BOSTON ONCOLOGY ARABIA.
This geographic spread reflects Heparin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Heparin Go? Top Importing Countries & Their Buyers
Trade flow of Heparin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Heparin imports from India, with a total trade value of $148.5M across 913 shipments — representing a 42.1% share of all Heparin exports. The average shipment value of $162.6K is above the global average of $76.9K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Heparin importers in United States: FRESENIUS KABI USA, LLC is the largest buyer, accounting for 30.4% ($45.1M) of this market's total imports.
• FRESENIUS KABI USA, LLC — $45.1M (30.4% of United States's total)
• EVERSANA — $28.2M (19.0% of United States's total)
• HOSPIRA INC — $16.3M (11.0% of United States's total)
Key Insight: United States's per-shipment average of $162.6K (111% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Heparin imports from India.
2Saudi Arabia
Saudi Arabia ranks as the second-largest destination for Heparin imports from India, with a total trade value of $43.5M across 223 shipments — representing a 12.3% share of all Heparin exports. The average shipment value of $195.2K is above the global average of $76.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Heparin importers in Saudi Arabia: BOSTON ONCOLOGY ARABIA is the largest buyer, accounting for 96.8% ($42.1M) of this market's total imports.
• BOSTON ONCOLOGY ARABIA — $42.1M (96.8% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $195.2K (154% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Heparin imports from India.
3Guatemala
Guatemala ranks as the third-largest destination for Heparin imports from India, with a total trade value of $30.6M across 22 shipments — representing a 8.7% share of all Heparin exports. The average shipment value of $1.4M is above the global average of $76.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Heparin importers in Guatemala: NUEVOS ETICOS NEOETHICALS, S.A. is the largest buyer, accounting for 94.2% ($28.8M) of this market's total imports.
• NUEVOS ETICOS NEOETHICALS, S.A. — $28.8M (94.2% of Guatemala's total)
Key Insight: Guatemala's per-shipment average of $1.4M (1710% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Guatemala is a key market for Heparin imports from India.
4Thailand
Thailand ranks as the fourth-largest destination for Heparin imports from India, with a total trade value of $27.3M across 28 shipments — representing a 7.8% share of all Heparin exports. The average shipment value of $976.7K is above the global average of $76.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Heparin importers in Thailand: E U PHARMACEUTICALS CO.,LTD is the largest buyer, accounting for 28.7% ($7.8M) of this market's total imports.
• E U PHARMACEUTICALS CO.,LTD — $7.8M (28.7% of Thailand's total)
Key Insight: Thailand's per-shipment average of $976.7K (1170% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Heparin imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Heparin imports from India, with a total trade value of $14.4M across 0 shipments — representing a 4.1% share of all Heparin exports. The average shipment value of $14.4M is above the global average of $76.9K, indicating high-value procurement contracts or branded formulations.
Key Insight: Philippines's per-shipment average of $14.4M (18676% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Heparin imports from India.
People Also Ask — Heparin Supplier & Trade Network
Who are the top suppliers of Heparin from India?+
Which companies buy Heparin from Indian manufacturers?+
Where does Heparin exported from India go?+
What is the market share of the top Heparin supplier from India?+
What is the average shipment value for Heparin exports from India?+
Is Heparin manufactured in India and exported globally?+
Which country imports the most Heparin from India?+
Who are the buyers of Heparin in Saudi Arabia?+
How concentrated is the Heparin supplier market in India?+
How do I find verified buyers for Heparin in specific countries?+
Heparin Trade Network — Key Takeaways
- 1GLAND PHARMA LTD is India's dominant Heparin exporter with a 21.0% market share and $74.0M in total exports — making it the single most important sourcing entity in this market.
- 2The top 391 suppliers collectively account for 52.6% of all tracked Heparin exports, with a combined trade value of $352.8M.
- 3United States is the largest destination market, absorbing 42.1% of India's Heparin exports ($148.5M). Saudi Arabia (12.3%) and Guatemala (8.7%) follow.
- 4With 4.6K total shipments averaging $76.9K each, the Heparin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include FRESENIUS KABI USA LLC,, EVERSANA, FRESENIUS KABI USA LLC,, EVERSANA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 137 countries
Network value: $352.8M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Heparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Heparin.
- 2.Flow Mapping: 391 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,586 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 137 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,586 Verified Shipments
391 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists